What is the management for placenta previa?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Placenta Previa

Diagnosis and Initial Assessment

Transvaginal ultrasound is the gold standard for diagnosing placenta previa, with 90.7% sensitivity and 96.9% specificity, and must be performed after initial transabdominal screening. 1, 2, 3

  • Begin with transabdominal ultrasound, then proceed to transvaginal ultrasound for definitive assessment of placental location relative to the internal cervical os. 2, 3
  • Measure the distance from the leading placental edge to the internal os—overlap of ≥15 mm at mid-trimester predicts persistence at delivery. 2, 3
  • Never perform digital pelvic examination until placenta previa has been excluded, as this can trigger catastrophic hemorrhage. 1, 2, 3
  • Use Doppler ultrasound to identify vasa previa and assess placental blood flow patterns, particularly for posterior placenta previa. 1, 3

Risk Stratification for Placenta Accreta Spectrum

All women with placenta previa and any prior cesarean delivery must be evaluated for placenta accreta spectrum disorder—the risk increases 7-fold after one cesarean and 56-fold after three cesarean deliveries. 1, 2, 3

  • Additional risk factors include advanced maternal age, high parity, prior uterine surgery, prior postpartum hemorrhage, Asherman syndrome, uterine anomalies, smoking, hypertension, and in vitro fertilization. 1, 2, 3
  • Consider MRI when ultrasound findings are concerning for placenta accreta, especially for posterior placenta previa or suspected placenta percreta. 1, 3
  • Failure to diagnose placenta accreta spectrum in this population can lead to catastrophic hemorrhage—this is the most critical pitfall to avoid. 2, 3

Follow-Up Imaging Protocol

  • Schedule ultrasound examinations at 18-20 weeks, 28-30 weeks, and 32-34 weeks to assess for previa resolution, placental location, and possible bladder invasion. 3
  • If placenta previa persists at the 28-30 week ultrasound, immediately refer to a level III or IV maternal care facility with multidisciplinary expertise. 3

Antepartum Activity Management

  • Women with asymptomatic placenta previa can continue moderate-to-vigorous physical activity before 28 weeks. 1, 2, 3
  • After 28 weeks, prohibit moderate-to-vigorous physical activity but allow activities of daily living and low-intensity walking. 1, 2, 3
  • Hospitalize immediately for any active bleeding. 1, 2, 3

Anemia Optimization

  • Maximize hemoglobin values during pregnancy by treating anemia with oral or intravenous iron as needed to prepare for potential hemorrhage at delivery. 1, 3

Delivery Timing

Plan cesarean delivery at 34 0/7 to 35 6/7 weeks of gestation for uncomplicated placenta previa—this balances neonatal complications against increased maternal bleeding risk after 36 weeks. 1, 2, 3

  • Administer antenatal corticosteroids when delivery is anticipated before 37 0/7 weeks. 1, 3
  • Do not delay delivery beyond 36 0/7 weeks, as approximately 50% of women with placenta accreta spectrum beyond 36 weeks require emergent delivery for hemorrhage. 1, 2, 3
  • Deliver earlier for persistent bleeding, preeclampsia, labor, rupture of membranes, or fetal compromise. 1, 2

Delivery Location and Team Assembly

Delivery must occur at a level III or IV maternal care facility with a multidisciplinary team including maternal-fetal medicine subspecialists, pelvic surgeons, urologists, interventional radiologists, obstetric anesthesiologists, and neonatologists. 1, 3

  • Ensure the facility has a blood bank capable of employing massive transfusion protocols. 1, 3
  • Notify the blood bank in advance due to the frequent need for large-volume blood transfusion. 1, 3
  • Coordinate preoperatively with anesthesiology, maternal-fetal medicine, neonatology, and expert pelvic surgeons. 1, 3

Intraoperative Management

  • Consider dorsal lithotomy positioning to allow vaginal access and optimal surgical visualization. 1
  • Inspect the uterus after peritoneal entry to determine placental location and optimize the uterine incision approach. 1
  • Make the uterine incision away from the placenta when possible. 1, 2
  • For placenta accreta spectrum, leave the placenta in situ after fetal delivery—never attempt forced placental removal as this causes profuse hemorrhage. 1, 2
  • For suspected bladder involvement, place ureteric stents and collaborate with urologic surgeons. 1, 3

Hemorrhage Management

Activate massive transfusion protocol early rather than late—delayed activation worsens outcomes. 2

  • Transfuse packed red blood cells, fresh frozen plasma, and platelets in a 1:1:1 to 1:2:4 ratio for acute hemorrhage. 1, 3
  • Obtain baseline laboratory assessment at bleeding initiation: platelet count, prothrombin time, partial thromboplastin time, and fibrinogen levels. 1, 3
  • Keep patients warm (>36°C) during surgery as clotting factors function poorly at lower temperatures. 1, 3
  • Re-dose prophylactic antibiotics if blood loss ≥1,500 ml. 1, 3
  • Consider tranexamic acid to reduce blood loss. 2, 3
  • For placenta accreta spectrum with uncontrollable bleeding, cesarean hysterectomy is necessary—this is the most accepted approach. 1, 2

Postoperative Care

  • Provide intensive hemodynamic monitoring in the early postoperative period, ideally in an intensive care unit setting. 1, 2, 3
  • Closely monitor volume status, urine output, blood loss, and hemodynamics. 1, 2, 3
  • Maintain a low threshold for reoperation if ongoing bleeding is suspected. 2, 3
  • Ensure adequate iron supplementation and follow-up of hemoglobin levels if significant blood loss occurred. 1, 3

References

Guideline

Management and Treatment of Placenta Previa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Placenta Previa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Placenta Previa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.